• Serb Galenika Says It Secures Certificate for Drug Sales in EU
  • Elan Drops as Royal Pharma Says Takeover May Fail
  • Royalty Pharma Says Elan Offer May Lapse Over Buyback
  • Bionor Pharma Surges After HIV Drug Study Progress: Oslo Mover
  • Wockhardt to Lose $17 Million in Sales as India Bans Painkiller
  • SAP, Pfizer-Teva, FIFA, Agilent: Intellectual Property
  • Glaxo Says Probe Finds No Evidence of China Unit Bribery
  • Eni’s Versalis Loses EU Top Court Appeal of Rubber Cartel Fine
  • Vaccine-Maker Litha Won’t Pay Dividends as It Looks for Buys
  • Sun Pharma Declines After $550 Million Pfizer Settlement
  • Indian Stocks Decline for Third Day Amid Global Selloff
  • Kasowitz, Sullivan & Cromwell, Jones Day: Business of Law
  • Elan Risking $2 Billion If Royalty Pharma Walks: Real M&A
  • Biggest Insurer Joins Executives Dumping Indian Stocks
  • Pfizer Reaches $2.15 Billion Protonix Accord With Teva
« Previous 1 2 3 4 5 Next »